Dr. Robert W. Holloway, MD

Dr. Holloway practices at Adventhealth Imaging Medical Plaza Orlando Mri CT - HOPD in Orlando, Florida.

Dr. Holloway's NPI, 1538109137, was assigned on June 8, 2006. Dr. Holloway graduated from Vanderbilt University School Of Medicine in 1983. Dr. Holloway holds Florida license ME58193.

Dr. Holloway's primary practice is Adventhealth Imaging Medical Plaza Orlando Mri CT - HOPD, at 2501 N Orange Ave, Orlando, FL 32804.

Dr. Holloway's primary practice is Adventhealth Imaging Medical Plaza Orlando Mri CT - HOPD in Orlando, Florida. Dr. Holloway is also affiliated with AdventHealth Orlando. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Holloway to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Holloway's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holloway practices, 9 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Holloway's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Holloway is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Holloway's licenses on file in 3 states: Florida, Alabama and Maryland.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Holloway treats.

CMS data shows 1,244 Medicare services from Dr. Holloway across 11 procedure codes in 2024, for 312 Medicare patients. Medicare paid $130,893 for them.

CMS counts 312 Medicare patients who saw Dr. Holloway in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Holloway's median patient age at 68, with 99% women.

In 2024, Dr. Holloway wrote 1,161 Medicare Part D claims for 300 patients. 86% of them were for generic drugs. CMS names the drug for 961 of them, across 19 drugs with 11 or more claims each, at $1,172,179 in total drug cost. In 2023, CMS named 711 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Holloway for performance year 2024, reported as part of a group. Dr. Holloway accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holloway as offering telehealth. CMS counts 44 procedures of removal of the uterus by Dr. Holloway, more than 99% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 116 papers to Dr. Holloway, published from 2007 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Ovarian Neoplasms, Endometrial Neoplasms and Hysterectomy. Dr. Holloway has published most often in Gynecol Oncol. Dr. Holloway's most frequent co-authors are James Erasmus Kendrick, MD, Neil J. Finkler, MD and Glenn E. Bigsby, DO.

Dmand AI links Dr. Holloway to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Endometrial Neoplasms, Fallopian Tube Diseases and Fallopian Tube Neoplasms. Open Payments lists research payments to Dr. Holloway that name 1 trial.

CMS Open Payments shows 631 general payments to Dr. Holloway from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. GlaxoSmithKline, LLC. paid the most, $148,483. It also lists 11 research payments totaling $2,111 from 2024 to 2025, naming 1 clinical trial.

Dmand AI lists 13 awards for Dr. Holloway, most recently Top Doctors: Florida in 2014.

Dr. Holloway graduated from Vanderbilt University School Of Medicine in 1983. Dr. Holloway is a member of American College of Obstetricians and Gynecologists, ACS and ASCO.

Dr. Holloway is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.